Venkat R. Thalladi

Person

Foster City, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Formulation of a pan-JAK inhibitor
- Patent number 11,795,180
- Issue date Oct 24, 2023
- Theravance Biopharma R&D IP, LLC
- Bernardus Joseph Nitert
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for treating Crohn's disease using 3-((1R,3s,5S)-3-((7-((5-...
- Patent number 11,780,852
- Issue date Oct 10, 2023
- Theravance Biopharma R&D IP, LLC
- Ryan Hudson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-...
- Patent number 11,718,591
- Issue date Aug 8, 2023
- Theravance Biopharma R&D IP, LLC
- Adam D. Hughes
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
JAK kinase inhibitor compounds for treatment of respiratory disease
- Patent number 11,718,616
- Issue date Aug 8, 2023
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyl...
- Patent number 11,642,332
- Issue date May 9, 2023
- Theravance Biopharma R&D IP, LLC
- Melissa Fleury
- C30 - CRYSTAL GROWTH
Information Patent Grant
Combination dosage form of a mu opioid receptor antagonist and an o...
- Patent number 11,452,723
- Issue date Sep 27, 2022
- Theravance Biopharma R&D IP, LLC
- Shaoling Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-...
- Patent number 11,230,536
- Issue date Jan 25, 2022
- Theravance Biopharma R&D IP, LLC
- Adam D. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fused imidazo-piperidine JAK inhibitor compound
- Patent number 11,160,810
- Issue date Nov 2, 2021
- Theravance Biopharma R&D IP, LLC
- Robert Murray McKinnell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treatment using a JAK inhibitor compound
- Patent number 11,160,800
- Issue date Nov 2, 2021
- Theravance Biopharma R&D IP, LLC
- Venkat R. Thalladi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyl...
- Patent number 11,033,533
- Issue date Jun 15, 2021
- Theravance Biopharma R&D IP, LLC
- Melissa Fleury
- C30 - CRYSTAL GROWTH
Information Patent Grant
Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors
- Patent number 10,968,205
- Issue date Apr 6, 2021
- Theravance Biopharma R&D IP, LLC
- Robert Murray McKinnell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for treating ulcerative colitis using 3-((1R,3s,5S)-3-((7-(...
- Patent number 10,947,254
- Issue date Mar 16, 2021
- Theravance Biopharma R&D IP, LLC
- Ryan Hudson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Combination dosage form of a mu opioid receptor antagonist and an o...
- Patent number 10,946,009
- Issue date Mar 16, 2021
- Theravance Biopharma R&D IP, LLC
- Shaoling Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
JAK kinase inhibitor compounds for treatment of respiratory disease
- Patent number 10,913,740
- Issue date Feb 9, 2021
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-...
- Patent number 10,752,599
- Issue date Aug 25, 2020
- Theravance Biopharma R&D IP, LLC
- Adam D. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyl...
- Patent number 10,548,879
- Issue date Feb 4, 2020
- Theravance Biopharma R&D IP, LLC
- Melissa Fleury
- C30 - CRYSTAL GROWTH
Information Patent Grant
Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors
- Patent number 10,538,513
- Issue date Jan 21, 2020
- Theravance Biopharma R&D IP, LLC
- Robert Murray McKinnell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline solvate comprising 3-((1R,3s,5S)-3-((7-((5-methyl-1H-py...
- Patent number 10,494,382
- Issue date Dec 3, 2019
- Theravance Biopharma R&D IP, LLC
- Xiaojun Huang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused imidazo-piperidine JAK inhibitor compound
- Patent number 10,493,077
- Issue date Dec 3, 2019
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline(2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-bipheny]-4-yl)-2-(e...
- Patent number 10,472,335
- Issue date Nov 12, 2019
- Theravance Biopharma R&D IP, LLC
- Adam D. Hughes
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors
- Patent number 10,392,368
- Issue date Aug 27, 2019
- Theravance Biopharma R&D IP, LLC
- Erik Fenster
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Combination dosage form of a mu opioid receptor antagonist and an o...
- Patent number 10,369,142
- Issue date Aug 6, 2019
- Theravance Biopharma R&D IP, LLC
- Shaoling Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystalline forms of a JAK inhibitor compound
- Patent number 10,251,874
- Issue date Apr 9, 2019
- Theravance Biopharma R&D IP, LLC
- Marta Dabros
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
JAK kinase inhibitor compounds for treatment of respiratory disease
- Patent number 10,183,942
- Issue date Jan 22, 2019
- Theravance Biopharma R&D IP, LLC
- Noah Benjamin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyl...
- Patent number 10,172,834
- Issue date Jan 8, 2019
- Theravance Biopharma R&D IP, LLC
- Melissa Fleury
- C30 - CRYSTAL GROWTH
Information Patent Grant
Crystalline(2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(...
- Patent number 10,100,021
- Issue date Oct 16, 2018
- Theravance Biopharma R&D IP, LLC
- Adam D. Hughes
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline form of 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)...
- Patent number 10,072,026
- Issue date Sep 11, 2018
- Theravance Biopharma R&D IP, LLC
- Xiaojun Huang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
(2R,4R)-5-(5′-Chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyl...
- Patent number 9,872,855
- Issue date Jan 23, 2018
- Theravance Biopharma R&D IP, LLC
- Melissa Fleury
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
(2S,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-...
- Patent number 9,868,698
- Issue date Jan 16, 2018
- Theravance Biopharma R&D IP, LLC
- Adam D. Hughes
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
(2S,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-...
- Patent number 9,670,143
- Issue date Jun 6, 2017
- Theravance Biopharma R&D IP, LLC
- Adam D. Hughes
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
CRYSTALLINE (2S,4R)-5-(5'-CHLORO-2'-FLUORO-[1,1'-BIPHENYL]-4-YL)-2-...
- Publication number 20240327360
- Publication date Oct 3, 2024
- THERAVANCE BIOPHARMA R&D IP, LLC
- Adam D. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NAPHTHYRIDINE COMPOUNDS AS JAK KINASE INHIBITORS
- Publication number 20240132520
- Publication date Apr 25, 2024
- THERAVANCE BIOPHARMA R&D IP, LLC
- Ryan Hudson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
JAK KINASE INHIBITOR COMPOUNDS FOR TREATMENT OF RESPIRATORY DISEASE
- Publication number 20220306624
- Publication date Sep 29, 2022
- THERAVANCE BIOPHARMA R&D IP, LLC
- Paul R. Fatheree
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLINE FORM OF A DIHYDROCHLORIDE SALT OF A JAK INHIBITOR COMPOUND
- Publication number 20220306626
- Publication date Sep 29, 2022
- THERAVANCE BIOPHARMA R&D IP, LLC
- Jerry Nzerem
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE (2S,4R)-5-(5'-CHLORO-2'-FLUORO-[1,1'-BIPHENYL]-4-YL)-2-...
- Publication number 20220242836
- Publication date Aug 4, 2022
- THERAVANCE BIOPHARMA R&D IP, LLC
- Adam D. Hughes
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZOLO AND TRIAZOLO BICYCLIC COMPOUNDS AS JAK KINASE INHIBITORS
- Publication number 20220119369
- Publication date Apr 21, 2022
- THERAVANCE BIOPHARMA R&D IP, LLC
- ROBERT MURRAY MCKINNELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FORMULATION OF A PAN-JAK INHIBITOR
- Publication number 20220112220
- Publication date Apr 14, 2022
- JANSSEN BIOTECH, INC.
- Bernardus Joseph Nitert
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
(2R,4R)-5-(5'-CHLORO-2'-FLUOROBIPHENYL-4-YL)-2-HYDROXY-4-[(5-METHYL...
- Publication number 20210401808
- Publication date Dec 30, 2021
- THERAVANCE BIOPHARMA R&D IP, LLC
- Melissa Fleury
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NAPHTHYRIDINE COMPOUNDS AS JAK KINASE INHIBITORS
- Publication number 20210179637
- Publication date Jun 17, 2021
- THERAVANCE BIOPHARMA R&D IP, LLC
- Ryan Hudson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION DOSAGE FORM OF A MU OPIOID RECEPTOR ANTAGONIST AND AN O...
- Publication number 20210161884
- Publication date Jun 3, 2021
- THERAVANCE BIOPHARMA R&D IP, LLC
- Shaoling Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLINE (2S,4R)-5-(5'-CHLORO-2'-FLUORO-[1,1'-BIPHENYL]-4-YL)-2-...
- Publication number 20210061776
- Publication date Mar 4, 2021
- THERAVANCE BIOPHARMA R&D IP, LLC
- Adam D. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
(2R,4R)-5-(5'-CHLORO-2'-FLUOROBIPHENYL-4-YL)-2-HYDROXY-4-[(5-METHYL...
- Publication number 20200281900
- Publication date Sep 10, 2020
- THERAVANCE BIOPHARMA R&D IP, LLC
- Melissa Fleury
- C30 - CRYSTAL GROWTH
Information Patent Application
PYRAZOLO AND TRIAZOLO BICYCLIC COMPOUNDS AS JAK KINASE INHIBITORS
- Publication number 20200216423
- Publication date Jul 9, 2020
- THERAVANCE BIOPHARMA R&D IP, LLC
- ROBERT MURRAY MCKINNELL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE (2S,4R)-5-(5'-CHLORO-2'-FLUORO-[1,1'-BIPHENYL]-4-YL)-2-...
- Publication number 20200157061
- Publication date May 21, 2020
- THERAVANCE BIOPHARMA R&D IP, LLC
- Adam D. Hughes
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF TREATMENT USING A JAK INHIBITOR COMPOUND
- Publication number 20200121669
- Publication date Apr 23, 2020
- THERAVANCE BIOPHARMA R&D IP, LLC
- VENKAT R. THALLADI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease
- Publication number 20200087303
- Publication date Mar 19, 2020
- THERAVANCE BIOPHARMA R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED IMIDAZO-PIPERIDINE JAK INHIBITOR COMPOUND
- Publication number 20200046719
- Publication date Feb 13, 2020
- THERAVANCE BIOPHARMA R&D IP, LLC
- ROBERT MURRAY MCKINNELL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NAPHTHYRIDINE COMPOUNDS AS JAK KINASE INHIBITORS
- Publication number 20200040010
- Publication date Feb 6, 2020
- THERAVANCE BIOPHARMA R&D IP, LLC
- Ryan Hudson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION DOSAGE FORM OF A MU OPIOID RECEPTOR ANTAGONIST AND AN O...
- Publication number 20190321350
- Publication date Oct 24, 2019
- THERAVANCE BIOPHARMA R&D IP, LLC
- Shaoling Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRAZOLO AND TRIAZOLO BICYCLIC COMPOUNDS AS JAK KINASE INHIBITORS
- Publication number 20190315724
- Publication date Oct 17, 2019
- THERAVANCE BIOPHARMA R&D IP, LLC
- ROBERT MURRAY MCKINNELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
(2R,4R)-5-(5'-CHLORO-2'-FLUOROBIPHENYL-4-YL)-2-HYDROXY-4-[(5-METHYL...
- Publication number 20190269659
- Publication date Sep 5, 2019
- THERAVANCE BIOPHARMA R&D IP, LLC
- Melissa Fleury
- C30 - CRYSTAL GROWTH
Information Patent Application
PYRAZOLO AND TRIAZOLO BICYCLIC COMPOUNDS AS JAK KINASE INHIBITORS
- Publication number 20190040043
- Publication date Feb 7, 2019
- THERAVANCE BIOPHARMA R&D IP, LLC
- ERIK FENSTER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE(2S,4R)-5-(5'-CHLORO-2'-FLUORO-[1,1'-BIPHENY]-4-YL)-2-(E...
- Publication number 20190002416
- Publication date Jan 3, 2019
- THERAVANCE BIOPHARMA R&D IP, LLC
- Adam D. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NAPHTHYRIDINE COMPOUNDS AS JAK KINASE INHIBITORS
- Publication number 20180354974
- Publication date Dec 13, 2018
- THERAVANCE BIOPHARMA R&D IP, LLC
- Xiaojun Huang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease
- Publication number 20180319796
- Publication date Nov 8, 2018
- THERAVANCE BIOPHARMA R&D IP, LLC
- Noah Benjamin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF TREATMENT USING A JAK INHIBITOR COMPOUND
- Publication number 20180311226
- Publication date Nov 1, 2018
- THERAVANCE BIOPHARMA R&D IP, LLC
- Venkat R. THALLADI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLINE FORMS OF A JAK INHIBITOR COMPOUND
- Publication number 20180311223
- Publication date Nov 1, 2018
- THERAVANCE BIOPHARMA R&D IP, LLC
- MARTA DABROS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSED IMIDAZO-PIPERIDINE JAK INHIBITOR COMPOUND
- Publication number 20180311255
- Publication date Nov 1, 2018
- THERAVANCE BIOPHARMA R&D IP, LLC
- PAUL R. FATHEREE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
(2R,4R)-5-(5'-CHLORO-2'-FLUOROBIPHENYL-4-YL)-2-HYDROXY-4-[(5-METHYL...
- Publication number 20180228774
- Publication date Aug 16, 2018
- THERAVANCE BIOPHARMA R&D IP, LLC
- Melissa Fleury
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION DOSAGE FORM OF A MU OPIOID RECEPTOR ANTAGONIST AND AN O...
- Publication number 20180050028
- Publication date Feb 22, 2018
- THERAVANCE BIOPHARMA R&D IP, LLC
- Shaoling Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Venkat R. Thalladi

Person

Patents Grantslast 30 patents

Formulation of a pan-JAK inhibitor

Methods for treating Crohn's disease using 3-((1R,3s,5S)-3-((7-((5-...

Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-...

JAK kinase inhibitor compounds for treatment of respiratory disease

(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyl...

Combination dosage form of a mu opioid receptor antagonist and an o...

Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-...

Fused imidazo-piperidine JAK inhibitor compound

Methods of treatment using a JAK inhibitor compound

(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyl...

Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors

Methods for treating ulcerative colitis using 3-((1R,3s,5S)-3-((7-(...

Combination dosage form of a mu opioid receptor antagonist and an o...

JAK kinase inhibitor compounds for treatment of respiratory disease

Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-...

(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyl...

Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors

Crystalline solvate comprising 3-((1R,3s,5S)-3-((7-((5-methyl-1H-py...

Fused imidazo-piperidine JAK inhibitor compound

Crystalline(2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-bipheny]-4-yl)-2-(e...

Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors

Combination dosage form of a mu opioid receptor antagonist and an o...

Crystalline forms of a JAK inhibitor compound

JAK kinase inhibitor compounds for treatment of respiratory disease

(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyl...

Crystalline(2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(...

Crystalline form of 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)...

(2R,4R)-5-(5′-Chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyl...

(2S,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-...

(2S,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-...

Patents Applicationslast 30 patents

CRYSTALLINE (2S,4R)-5-(5'-CHLORO-2'-FLUORO-[1,1'-BIPHENYL]-4-YL)-2-...

NAPHTHYRIDINE COMPOUNDS AS JAK KINASE INHIBITORS

JAK KINASE INHIBITOR COMPOUNDS FOR TREATMENT OF RESPIRATORY DISEASE

CRYSTALLINE FORM OF A DIHYDROCHLORIDE SALT OF A JAK INHIBITOR COMPOUND

CRYSTALLINE (2S,4R)-5-(5'-CHLORO-2'-FLUORO-[1,1'-BIPHENYL]-4-YL)-2-...

PYRAZOLO AND TRIAZOLO BICYCLIC COMPOUNDS AS JAK KINASE INHIBITORS

FORMULATION OF A PAN-JAK INHIBITOR

(2R,4R)-5-(5'-CHLORO-2'-FLUOROBIPHENYL-4-YL)-2-HYDROXY-4-[(5-METHYL...

NAPHTHYRIDINE COMPOUNDS AS JAK KINASE INHIBITORS

COMBINATION DOSAGE FORM OF A MU OPIOID RECEPTOR ANTAGONIST AND AN O...

CRYSTALLINE (2S,4R)-5-(5'-CHLORO-2'-FLUORO-[1,1'-BIPHENYL]-4-YL)-2-...

(2R,4R)-5-(5'-CHLORO-2'-FLUOROBIPHENYL-4-YL)-2-HYDROXY-4-[(5-METHYL...

PYRAZOLO AND TRIAZOLO BICYCLIC COMPOUNDS AS JAK KINASE INHIBITORS

CRYSTALLINE (2S,4R)-5-(5'-CHLORO-2'-FLUORO-[1,1'-BIPHENYL]-4-YL)-2-...

METHODS OF TREATMENT USING A JAK INHIBITOR COMPOUND

JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease

FUSED IMIDAZO-PIPERIDINE JAK INHIBITOR COMPOUND

NAPHTHYRIDINE COMPOUNDS AS JAK KINASE INHIBITORS

COMBINATION DOSAGE FORM OF A MU OPIOID RECEPTOR ANTAGONIST AND AN O...

PYRAZOLO AND TRIAZOLO BICYCLIC COMPOUNDS AS JAK KINASE INHIBITORS

(2R,4R)-5-(5'-CHLORO-2'-FLUOROBIPHENYL-4-YL)-2-HYDROXY-4-[(5-METHYL...

PYRAZOLO AND TRIAZOLO BICYCLIC COMPOUNDS AS JAK KINASE INHIBITORS

CRYSTALLINE(2S,4R)-5-(5'-CHLORO-2'-FLUORO-[1,1'-BIPHENY]-4-YL)-2-(E...

NAPHTHYRIDINE COMPOUNDS AS JAK KINASE INHIBITORS

JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease

METHODS OF TREATMENT USING A JAK INHIBITOR COMPOUND

CRYSTALLINE FORMS OF A JAK INHIBITOR COMPOUND

FUSED IMIDAZO-PIPERIDINE JAK INHIBITOR COMPOUND

(2R,4R)-5-(5'-CHLORO-2'-FLUOROBIPHENYL-4-YL)-2-HYDROXY-4-[(5-METHYL...

COMBINATION DOSAGE FORM OF A MU OPIOID RECEPTOR ANTAGONIST AND AN O...